Boston Biopharma Limited
About Boston Biopharma Limited
Categories
-
US
-
2017On CPHI since
-
25 - 49Employees
Company types
Primary activities
Products from Boston Biopharma Limited (3)
-
Product Goserelin Boston Biopharma
Goserelin is hormone therapy, classified as "LHRH agonist." (Endocrine Therapy)
It is indicated:
- in advanced breast cancer in pre and perimenopausal women suitable for hormonal manipulation
- as an alternative to chemotherapy in the standard of care for pre and perimenopausal women with estrogen... -
Product Bendamustine Boston Biopharma
Bendamustine is an alkylatic agent used alone (monotherapy) or in combination with other drugs for the treatment of chronic lymphocytic leukemia and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer.
-
Product Sevoflurane Boston Biopharma
Sevoflurane belongs to a group of medicines called general anesthetics. These work by temporarily reducing the activity of the body’s central nervous system. This causes a complete loss of sensation in the body, including loss of consciousness - allowing surgery to be carried out without pain or distre...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance